<unk>  is a rare cancer in developed nations with annual incidence varying from 0.3 to 1 per 100,000 per year accounting for around 0.4–0.6% of all malignancies. The annual incidence is approximately 1 in 100,000 men in the United States, 1 in 250,000 in Australia, and 0.82 per 100,000 in Denmark. In the United Kingdom, fewer than 500 men are diagnosed with<unk>  every year. However, in the developing world<unk>  is much more common. For instance, in Paraguay, Uruguay, Uganda and Brazil the incidence is 4.2, 4.4, 2.8 and 1.5–3.7 per 100,000, respectively. In some South American countries, Africa, and Asia, this cancer type constitutes up to 10% of malignant diseases in men. The lifetime risk has been estimated as 1 in 1,437 in the United States and 1 in 1,694 in Denmark.
Penile cancer
Urethral cancer
Bladder cancer
Testicular cancer
Hydrocele
Acute prostatitis
Urogenital fistula
Urethrocele